ENYO Pharma
Created in 2014
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
372 7,079Activities
Technologies
Entity types
Location
60 Av. Rockefeller, 69008 Lyon, France
Lyon
France
Employees
Scale: 11-50
Estimated: 31
SIREN
799831011Engaged corporates
8
3 5Added in Motherbase
5 years, 6 months ago
biotech Value proposition
Developing therapeutics for diseases with impaired kidney function
ENYO Pharma is developing innovative therapeutics based on fibrolytic and anti-inflammatory properties for diseases with impaired kidney function.
The company is conducting Phase 2 trials with its lead compound Vonafexor in Chronic Kidney Diseases (CKD) and rare kidney disease such as Alport syndrome, and liver diseases (such as Non-Alcoholic SteatoHepatitis, NASH).
Liver-related infectious diseases such as chronic Hepatitis B and Hepatitis D are also addressed with Vonafexor.Original language
Développer des thérapies pour les maladies rénales chroniques
ENYO Pharma est une société biopharmaceutique au stade clinique.
Notre mission est de développer des molécules aux propriétés fibrolytiques et anti-inflammatoires pour améliorer la qualité de vie des patients souffrant d’insuffisance rénale.
Vonafexor est actuellement en Phase 2 pour le traitement du syndrome d’Alport, une maladie rénale rare et des maladies rénales chroniques.
Les maladies infectieuses hépatiques telles que l’Hépatite B et l'Hépatite D sont également abordées avec Vonafexor.
ENYO Pharma – Developing therapeutics for diseases with impaired kidney function
https://www.enyopharma.com/
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 La Tribune Media, Newspapers | La Tribune Media, Newspapers | Other 14 Jan 2020 | | |
 Boston Consulting Group (BCG) Consulting, Business Consulting and Services | Boston Consulting Group (BCG) Consulting, Business Consulting and Services | Not capitalistic Partnership Not event 30 Jun 2022 | | |
 European Commission European Union, Environmental Services | European Commission European Union, Environmental Services | Other 30 Jun 2022 | | |
 Bpifrance Bank, Banking | Bpifrance Bank, Banking | Other 27 Dec 2018 30 Jun 2022 | | |
 Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Lyonbiopôle Auvergne-Rhône-Alpes Public business cluster, Biotechnology, French Cluster, Biotechnology Research | Other 14 Dec 2023 | | |
 Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Sanofi Pharmaceutical, Pharmaceutical Manufacturing | Other 13 Jun 2019 | | |
 CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Capitalistic Partnership Not event 12 Feb 2024 | | |
 Sofinnova Partners Financial Services | Sofinnova Partners Financial Services | Other 4 Jan 2024 | | |